Eli Lilly and Company (NYSE: LLY), Indiana University’s Richard M. Fairbanks School of Public Health at IUPUI and Eskenazi Health have launched of a new neighborhood-based, data-driven pilot in Indianapolis to help address the high incidence of diabetes. Building on similar efforts Lilly has developed in lower-income communities in Mexico, India and South Africa, the $7-million, five-year program will focus on three Indianapolis neighborhoods with significant health disparities and a high incidence of diabetes: the Coalition of Northeast Neighborhoods, Northwest Neighborhood and Near Westside Neighborhood.
Patrice Duckett’s Story
